Rapidly exacerbating tuberculosis
نویسندگان
چکیده
منابع مشابه
Endobronchial inflammatory pseudotumour exacerbating asthma.
Primary pulmonary tumours are rare in the paediatric population. Of the benign tumours, the most common is the inflammatory pseudotumour (plasma cell granuloma). It can present as a variety of non-specific symptoms which may delay diagnosis. It usually occupies a peripheral pulmonary location and gives rise to symptoms due to its local mass effect and destructive invasion. We report the case of...
متن کاملDrug susceptibility testing of rapidly growing mycobacteria in extrapulmonary tuberculosis.
There has been an increasing awareness of the rapidly growing mycobacteria (RGM), of which numerous species and phylogenetic groups are clearly established human pathogens. It is important to appropriately distinguish RGM from other mycobacteria, as first-line antituberculous drugs are ineffective for their treatment. Variability in susceptibility of RGM is seen in relation to species, differen...
متن کاملRapidly Changing Tachyarrhythmia in Acute Stroke
Introduction: we report a 56-year-olds female with supraventricular arrhythmia due acute ischemic stroke without structural heart disease. Case Description: A patient presented with sudden onset of lethargy, right hemiplegia, and global aphasia. There was previous history of stroke 1 year ago presented with left hemiplegia that recovered completely during 10 days. There was no history of comorb...
متن کاملFactors Contributing to Exacerbating Vulnerabilities in Global Clinical Trials
Background: Although policies and guidelines make use of the concept of vulnerability, few define it. The European Union's directive for clinical trials does not include explanations for or the reasoning behind the designation of certain groups as vulnerable. Emerging economies from lower middle-income countries have, in recent years, had the largest average annual growth rate, as well as incre...
متن کاملExacerbating and reversing lysosomal storage diseases: from yeast to humans
Lysosomal storage diseases (LSDs) arise from monogenic deficiencies in lysosomal proteins and pathways and are characterized by a tissue-wide accumulation of a vast variety of macromolecules, normally specific to each genetic lesion. Strategies for treatment of LSDs commonly depend on reduction of the offending metabolite(s) by substrate depletion or enzyme replacement. However, at least 44 of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Global Imaging Insights
سال: 2017
ISSN: 2399-7397
DOI: 10.15761/gii.1000118